SPAGO NANOMEDICAL

spago-nanomedical-logo

Spago Nanomedical is a company performing research and development within nanomedicine.

#SimilarOrganizations #People #Financial #Website #More

SPAGO NANOMEDICAL

Social Links:

Industry:
Biotechnology Health Care

Address:
Lund, Skane Lan, Sweden

Country:
Sweden

Website Url:
http://www.spagonanomedical.se

Total Employee:
11+

Status:
Active

Total Funding:
500 K SEK

Technology used in webpage:
SPF DoubleClick.Net CPanel SSL


Similar Organizations

exo-therapeutics-logo

Exo Therapeutics

Exo Therapeutics is a small molecule drug discovery and development company.

novavax-logo

Novavax

Novavax is a clinical-stage biotechnology company focused on the discovery and development of innovative vaccines.

novellus-logo

Novellus

Novellus is a biotechnology company working to develop engineered cellular medicines.

piqur-therapeutics-logo

PIQUR Therapeutics

PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.

summit-therapeutics-logo

Summit Therapeutics

Summit Therapeutics is a clinical-stage drug discovery and development company.

Current Employees Featured

paul-hargreaves_image

Paul Hargreaves
Paul Hargreaves Chief Development Officer @ Spago Nanomedical
Chief Development Officer
2021-10-01

oskar-axelsson_image

Oskar Axelsson
Oskar Axelsson CSO @ Spago Nanomedical
CSO

paul-hargreaves_image

Paul Hargreaves
Paul Hargreaves Chief Development Officer @ Spago Nanomedical
Chief Development Officer

mats-hansen_image

Mats Hansen
Mats Hansen CEO @ Spago Nanomedical
CEO
2015-01-01

Stock Details


Company's stock symbol is NASDAQ:SPAGO

Investors List

vinnova_image

Vinnova

Vinnova investment in Grant - Spago Nanomedical

Official Site Inspections

http://www.spagonanomedical.se

  • Host name: zeus.oderland.com
  • IP address: 91.201.60.24
  • Location: Sweden
  • Latitude: 59.3247
  • Longitude: 18.056
  • Timezone: Europe/Stockholm

Loading ...

More informations about "Spago Nanomedical"

Spago Nanomedical

Apr 9, 2025 Spago Nanomedical AB is a Swedish nanomedicines company in clinical development phase. The company´s development projects are based on a platform of โ€ฆSee details»

About - Spago Nanomedical

Shareholders who wish to submit proposals to the nomination committee are welcome to send them by e-mail to [email protected]. Proposals shall be submitted no โ€ฆSee details»

Spago Nanomedical » Nomination committeeโ€™s proposal for a โ€ฆ

Mar 20, 2025 For further information, please contact Mats Hansen, CEO Spago Nanomedical AB, +46 46 811 88, [email protected] Spago Nanomedical AB is a โ€ฆSee details»

Notice To Annual General Meeting of Spago Nanomedical AB (PUBL)

Apr 9, 2025 For further information, please contact Mats Hansen, CEO Spago Nanomedical AB, +46 46 811 88, [email protected] Spago Nanomedical AB is a Swedish โ€ฆSee details»

Spago Nanomedical AB | LinkedIn

Spago Nanomedical AB - Fullt fokus på Tumorad Se intervjun här: https://lnkd.in/d34iX2kN Vi har intervjuat Mats Hansen, VD för Spago Nanomedical, för att diskutera den senaste โ€ฆSee details»

ANNUAL REPORT - storage.mfn.se

Spago Nanomedical AB (publ) org.nr. 556574-5048 Scheelevägen 22 SE-223 63 Lund, Sweden Tel: +46 46 811 88 www.spagonanomedical.se Significant events 04 CEO statement by Mats โ€ฆSee details»

Spago Nanomedical - Crunchbase Company Profile & Funding

SpagoPix: A gadolinium-free MRI contrast agent, SN132D, designed for precise imaging of solid tumors and other severe diseases. Tumorad: A radionuclide therapy project using โ€ฆSee details»

Spago Nanomedical AB Company Description - Stock Analysis

Mar 21, 2025 Company profile for Spago Nanomedical AB (publ) (STO:SPAGO) with a description, list of executives, contact details and other key facts.See details»

Nomination Committee's Proposal for a New Chairman and

Mar 20, 2025 For further information, please contact Mats Hansen, CEO Spago Nanomedical AB, +46 46 811 88, [email protected] Spago Nanomedical AB is a โ€ฆSee details»

Spagoโ€™s CEO: โ€œWe want to expand cancer treatment with effective ...

Dec 19, 2024 Her extensive pharmaceutical development and commercial production expertise add valuable capabilities to the company. With a sharpened organization aligned with the โ€ฆSee details»

Spago Nanomedical » Valberedningens förslag till ny ordförande โ€ฆ

Mar 20, 2025 För ytterligare information, kontakta Mats Hansen, VD Spago Nanomedical AB, +46 46 811 88, [email protected]See details»

Spago Nanomedical - placera.se

Mar 20, 2025 For further information, please contact Mats Hansen, CEO Spago Nanomedical AB, +46 46 811 88, [email protected] Spago Nanomedical AB is a โ€ฆSee details»

Spago Nanomedical AB - Drug pipelines, Patents, Clinical trials

For further information, please contact Mats Hansen, CEO Spago Nanomedical AB, +46 46 811 88, [email protected] Spago Nanomedical AB is a Swedish company in โ€ฆSee details»

ANNUAL REPORT - storage.mfn.se

Spago Nanomedical AB (publ) org.nr. 556574-5048 Scheelevägen 22 SE-223 63 Lund, Sweden Phone: +46 46 811 88 www.spagonanomedical.se Contents Significant events during the year โ€ฆSee details»

MFN.se > Spago Nanomedical > Nomination committee's โ€ฆ

Mar 20, 2025 For further information, please contact Mats Hansen, CEO Spago Nanomedical AB, +46 46 811 88, [email protected] Spago Nanomedical AB is a โ€ฆSee details»

Spago Nanomedical - Overview, News & Competitors - ZoomInfo

Spago Nanomedical contact info: Phone number: +46 4681188 Website: www.spagonanomedical.se What does Spago Nanomedical do? Spago Nanomedical AB is a โ€ฆSee details»

Valberedningens förslag till ny ordförande och sammansättning av โ€ฆ

Mar 20, 2025 För ytterligare information, kontakta Mats Hansen, VD Spago Nanomedical AB, +46 46 811 88, [email protected] Spago Nanomedical AB är ett svenskt โ€ฆSee details»

Spago Nanomedical - Craft

Spago Nanomedical has 1 employees at their 1 location and kr1.91 m in annual revenue in FY 2024. See insights on Spago Nanomedical including office locations, competitors, revenue, โ€ฆSee details»

Spago Nanomedical publishes the annual report for 2024

6 days ago For further information, please contact Mats Hansen, CEO Spago Nanomedical AB, +46 46 811 88, [email protected] Spago Nanomedical AB is a Swedish โ€ฆSee details»

Spago Nanomedical Publishes The Annual Report for 2024

5 days ago For further information, please contact Mats Hansen, CEO Spago Nanomedical AB, +46 46 811 88, [email protected]. Spago Nanomedical AB is a Swedish โ€ฆSee details»

linkstock.net © 2022. All rights reserved